RxDoctor Payments Data

Justin Jones, MD

Family Medicine · San Angelo, TXNPI 1598112740

Payments from drug & device makers

$1,070in general payments, 2019–2025

Across 65 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$526
  • Amgen$103
  • Novo Nordisk$93
  • Lilly USA, LLC$59
  • Pfizer$47
  • GSK$42
  • plus $199 from 10 others

What the payments were for

  • Food & beverage$1,070100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,070 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$207,298
Medicare patients
343
Services billed
3,521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide47$68,911
OzempicSemaglutide49$47,925
EliquisApixaban47$41,124
JardianceEmpagliflozin42$39,331
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$36,138
FarxigaDapagliflozin Propanediol21$30,431
MounjaroTirzepatide15$17,569
MyrbetriqMirabegron12$15,682
XareltoRivaroxaban11$14,716
Tresiba Flextouch U-100Insulin Degludec13$14,597
Tresiba Flextouch U-200Insulin Degludec14$8,400
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$8,026
LivaloPitavastatin Calcium16$7,606
Albuterol Sulfate HfaAlbuterol Sulfate165$5,834
Atorvastatin Calcium475$4,158

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$59$86,48062 claims
Novo NordiskOzempic$93$47,92549 claims
PfizerEliquis$47$41,12447 claims
Boehringer IngelheimJardiance$24$39,33142 claims
GSKTrelegy Ellipta$42$36,13852 claims
Astellas Pharma US IncMyrbetriq$22$15,68212 claims
Johnson & JohnsonXarelto$25$14,71611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Angelo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →